ReviewMaterials (Basel, Switzerland)2025
Antimicrobial Biomaterials Based on Composites of Metal Nanoparticles and Plant Extracts.
Review in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The global challenge of antimicrobial resistance, as well as the need to develop safe and environmentally sustainable materials, has served to stimulate research interest in antimicrobial technologies. The abundance, degradability and environmental friendliness of biopolymers means that they are widely used in medicine, pharmacy, and cosmetology. The focus of this mini review is the development of biopolymer matrices with antimicrobial properties imparted via the inclusion of metal nanoparticles and plant extracts. The review also examines innovative technologies, including photocatalytic systems and intelligent coatings with mechanisms for the controlled release of active substances that can be used to combat microbial infections. We believe that such materials have significant potential for eventual translation to products in the real world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.